Research graph
References from Progress and Challenges in Kawasaki Disease: Increasingly International. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1542/peds.2026-076338 · 2026 · Admitted local publication
The treatment of Kawasaki syndrome with intravenous gamma globulin
10.1056/nejm198608073150601 · 1986 · External reference
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
10.1056/nejm199106063242305 · 1991 · External reference
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients
10.1161/01.cir.94.6.1379 · 1996 · External reference
Medium-term complications associated with coronary artery aneurysms after Kawasaki disease: a study from the International Kawasaki Disease Registry
10.1161/jaha.119.016440 · 2020 · External reference
Analysis of coronary arterial aneurysm regression in patients with Kawasaki disease by aneurysm severity: factors associated with regression
10.1161/jaha.121.022417 · 2023 · External reference
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study
10.1371/journal.pone.0038998 · 2012 · External reference
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
10.1016/s2352-4642(21)00270-4 · 2021 · External reference
Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis
10.1542/peds.2018-3341 · 2019 · External reference
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
10.1016/s0140-6736(11)61930-2 · 2012 · External reference
Randomized trial of adjunctive prednisolone for Kawasaki disease
10.1056/nejmoa2511478 · 2026 · External reference
